Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Hermine Agis"'
Autor:
Heinz Ludwig, Thomas Melchardt, Ilvy Schweitzer, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Niklas Zojer, Laurenz Schöffmann, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Wöll, Reinhard Ruckser, Boris Bozic, Maria‐Theresa Krauth, Andreas Petzer, Clemens Schmitt, Sigrid Machherndl‐Spandl, Hermine Agis, Michael Fillitz, Song‐Yau Wang, Stefan Knop, Richard Greil
Publikováno v:
eJHaem, Vol 5, Iss 3, Pp 494-504 (2024)
Abstract Understanding the impact of induction and maintenance therapy on patients’ quality of life (QoL) is important for treatment selection. This study aims to compare patient‐reported QoL between patients treated with KTd or KRd induction the
Externí odkaz:
https://doaj.org/article/024099f3e64d40079ea0f35121c1b82f
Autor:
Lina Z. Rüsing, Nicolas Kozakowski, Georg Jeryczynski, Lea Vospernik, Julia Riedl, Thomas Reiter, Heinz Gisslinger, Hermine Agis, Maria-Theresa Krauth
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
ABSTRACTObjective Cast nephropathy (CN) is the leading cause of acute kidney injury (AKI) in multiple myeloma (MM). Since it is sparsely documented why some patients with CN do achieve a renal response while others do not, we describe a single-center
Externí odkaz:
https://doaj.org/article/7c9dfcfc25e640378353bbb120d02a5d
Autor:
Giovanni Palladini, Stefan Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios A. Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M. Teresa Cibeira, Hermine Agis, Monique C. Minnema, Rui Bergantim, Roman Hájek, Cristina João, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh Wechalekar
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Systemic light-chain (AL) amyloidosis is a rare and debilitating disease. Advances have been made in new treatments in recent years, yet real-world data on the management of the disease are scarce. EMN23 is a retrospective, observational stu
Externí odkaz:
https://doaj.org/article/b66ddf1ad30c445e87c57bf515f577a5
Autor:
Heinz Ludwig, Thomas Melchardt, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Christoph Tinchon, Niklas Zojer, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Woell, Reinhard Ruckser, Boris Bozic, Maria Theresa Krauth, Andreas Petzer, Clemens A. Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Michael Fillitz, Song-Yau Wang, Stefan Knop, Bruno Paiva, Richard Greil
Publikováno v:
HemaSphere, Vol 7, p e55498d5 (2023)
Externí odkaz:
https://doaj.org/article/6331fd869261467da7450cd271583f31
Autor:
Clara Luhn, Hermine Agis, Elisabeth Hütterer, Ingrid Simonitsch‐Klupp, Christopher Dawoud, Anton Stift, Felix Harpain
Publikováno v:
Clinical Case Reports, Vol 11, Iss 8, Pp n/a-n/a (2023)
Key Clinical Message Amyloidosis is a heterogeneous disease characterized by tissue deposition of abnormally folded fibrillary proteins that can manifest itself by a wide variety of symptoms depending on the affected organs. GI involvement among amyl
Externí odkaz:
https://doaj.org/article/ed551f4a4199405da38b3127c178fd87
Autor:
Sara Oubari, Ute Hegenbart, Renate Schoder, Maximilian Steinhardt, Maria Papathanasiou, Tienush Rassaf, Andreas Thimm, Tim Hagenacker, Eyad Naser, Ulrich Duhrsen, Hans C. Reinhardt, Martin Kortum, Hermine Agis, Stefan Schonland, Alexander Carpinteiro
Publikováno v:
Haematologica, Vol 109, Iss 1 (2023)
Treatment of patients with Mayo stage IIIb light chain (AL) amyloidosis is still challenging, and the prognosis remains very poor. Mayo stage IIIb patients were excluded from the pivotal trial leading to the approval of daratumumab in combination wit
Externí odkaz:
https://doaj.org/article/8a76de74b39b4d61bccab7a8030ffca6
Autor:
Thomas Reiter, Sahra Pajenda, David O'Connell, Ciara Lynch, Sebastian Kapps, Hermine Agis, Alice Schmidt, Ludwig Wagner, Nelson Leung, Wolfgang Winnicki
Publikováno v:
Frontiers in Medicine, Vol 7 (2021)
Overproduction of human light chains (LCs) and immunoglobulins can result in various forms of renal disease such as cast nephropathy, monoclonal immunoglobulin deposition disease, LC proximal tubulopathy, AL amyloidosis, and crystal storing histiocyt
Externí odkaz:
https://doaj.org/article/66b5f44d3d4b4747ab1bbb912e863dff
Autor:
Matthias Preusser, Aysegül Ilhan-Mutlu, Gerald Prager, Thorsten Fuereder, Christine Marosi, Markus Raderer, Barbara Kiesewetter, Anna S Berghoff, Manuela Schmidinger, Maximilian Marhold, Rupert Bartsch, Thais Topakian, Hermine Agis, Thomas Brodowicz, Michael Krainer, Gottfried J Locker, Christiane Thallinger, Sabine Zöchbauer-Müller, Wolfgang Lamm
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Background Novel treatment modalities like targeted therapy and immunotherapy are currently changing treatment strategies and protocols in the field of medical oncology.Methods Numbers of patients and patient contacts admitted to medical oncology day
Externí odkaz:
https://doaj.org/article/c25a723c17b34991a47ad53813bf4e27
Autor:
Marlies Antlanger, Tobias Dust, Thomas Reiter, Alexandra Böhm, Wolfgang W. Lamm, Max Gornicec, Ella Willenbacher, David Nachbaur, Roman Weger, Werner Rabitsch, Susanne Rasoul-Rockenschaub, Nina Worel, Daniel Lechner, Hildegard Greinix, Felix Keil, Heinz Gisslinger, Hermine Agis, Maria-Theresa Krauth
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Renal impairment (RI) is a negative prognostic factor in Multiple Myeloma (MM) and affected patients are often excluded from autologous stem cell transplantation (ASCT). However, it remains unclear whether historically inferior ou
Externí odkaz:
https://doaj.org/article/772b7712f7614189872822ebf719be5b
Autor:
Franz Duca, Stefan Aschauer, Caroline Zotter-Tufaro, Christina Binder, Andreas A. Kammerlander, Benedikt Börries, Hermine Agis, Renate Kain, Christian Hengstenberg, Julia Mascherbauer, Diana Bonderman
Publikováno v:
Pulmonary Circulation, Vol 9 (2019)
Patients with transthyretin cardiac amyloidosis (TTR CA) suffer from impaired exercise capacity, have a poor quality of life (QoL), and approved treatments are lacking. Stimulators of the soluble guanylate cyclase are promising new pharmaceuticals in
Externí odkaz:
https://doaj.org/article/89ed84ed4f8f4cbd9478e5d1589fb287